Why Trust Remains the Primary Driver of Pharma Success
September 8, 2025 |
In an age of precision medicine, AI-driven drug discovery, and blockbuster biologics, it’s tempting to assume clinical trial outcomes alone dictate success in pharma. But the reality is more nuanced: trust remains the single most powerful determinant of whether a new therapy is adopted, prescribed, and embraced.
According to a 2024 McKinsey survey, 79% of healthcare decision-makers cited “brand credibility and trust” as a leading factor influencing prescribing and formulary decisions — ahead of price negotiations and even trial efficacy data. In a global pharma market set to reach $1.9 trillion by 2027, the implications are enormous.
For investors and boards alike, trust is more than reputation – it’s enterprise value. Bain’s 2024 Pharma Deal Report found companies with strong prescriber confidence trade at valuation multiples 25% higher than peers. Trust is not just a marketing priority; it is a growth lever that shapes shareholder return.
The three pillars of trust in pharma and medtech
- Scientific/ clinical endorsement
Peer influence drives prescribing behaviour. Studies show 62% of physicians are more likely to prescribe a therapy endorsed by respected KOLs or guideline committees. That’s why orchestrated medical affairs and peer-to-peer education programmes are vital in pharma and medtech. One recent example: the launch of a non-surgical intrauterine fibroid treatment in the UK used both patient-centred messaging and clinician storytelling to challenge the dominant surgical paradigm. Branded under the theme ‘Treat Smarter with Sonata’, the campaign emphasised the technology’s incisionless benefits and economic value. Early adopters were mobilised to co-create authentic video content. Their voices – credible, clinical, and compassionate, helped translate complex technical benefits into patient-centred outcomes. The result? A campaign that cut through the noise, reshaping perceptions of fibroid treatment by combining lived clinical insights with a powerful, trust-driven narrative. - Patient narratives
Clinical data opens the door, but patient voices bring therapies and technology to life. A 2025 Healthcare PR Benchmark found patient-led campaigns increased positive sentiment by over 40%, directly impacting prescribing behaviours. We saw just that when our global health tech company received NICE Guidance for its advanced wound dressings used in high-risk caesarean births. By focusing on the rich patient story, we were able to inform clinical decision makers about the impact and outcome of wound care choices on high-risk patients in a powerful and emotive way. - Transparent communication
In an era of instant fact-checking, overstating benefits or downplaying risks undermines credibility. Clinicians, payers, and patients now expect open access not just to pivotal trial results, but also to post-market surveillance, safety updates, and health economic data. Acknowledging both strengths and limitations of a therapy or new technology signals maturity and builds long-term trust – positioning pharma companies as partners in care, not just sellers of medicines.
Building trust through strategic communications
At EatMoreFruit, we help pharma and medtech companies embed trust into every stage of their brand journey. That means:
- Elevating trial outcomes through thought leadership and expert media
- Bringing forward patient and caregiver perspectives across multiple channels
- Anticipating risk and safety questions with clear, proactive communications
“Trust isn’t built in a press release; it’s earned through consistent, evidence-led storytelling,” says Paul Jarman, CEO of EatMoreFruit. “Our mission is to turn technical milestones and complex science into trusted narratives that accelerate adoption and build lasting value.”
Want to learn how we help pharma brands build trust that drives prescriptions, partnerships, and growth? Get in touch with us today.
This content was provided by EatMoreFruit
Company Details
Latest Content from EatMoreFruit
Europe Celebrates the Heart of Healthcare Decision-Making as Laboratory Medicine Professionals Take Centre Stage
Today, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) proudly marks European Laboratory Day, celebrating the professionals at the heart of healthcare decision making. Across Europe, laboratories will…
Why Trust Remains the Primary Driver of Pharma Success
In an age of precision medicine, AI-driven drug discovery, and blockbuster biologics, it’s tempting to assume clinical trial outcomes alone dictate success in pharma. But the reality is more nuanced:…
Shared Care, Digital Tools, and AI: What Do Nurses Really Think?
Shared care models, supported by effective communication and digital tools, are helping community nurses like Ashleigh Tropp empower patients and improve outcomes, especially in managing long-term conditions. For pharma and…
How can a digital PR strategy elevate your company’s profile? A spotlight on mental health
In the ever-evolving healthcare media landscape, Digital PR bridges the traditional benefits of reach, share of voice, and sentiment with the power of Search Engine Optimization (SEO)—delivering both meaningful connections…
Why events should be part of your 2025 growth strategy
Over eighty per cent of businesses rank in-person events as their most impactful marketing channel. In fact, 48 per cent of teams say events are more important today than pre-pandemic. When done…
How to make your Medical Education sync with your marketing by EatMoreFruit’s Bethany Lowes Bush
Medical education faces challenges. Time is scarce. Resources are tight. Information overload is real. But by delivering genuine value through innovative formats that respect how HCPs actually learn and consume…
Putting EU Lab Day on the Map
EU Lab Day 2024 made an impact – reaching over 1.7million people through media and social.
Want to Tell Your Story Differently in 2025?
From animation and gamification, to events, influencers, opinion leaders, and chatbots; there are tools and tactics which can engage health professionals, payors, patients and consumers. At EatMoreFruit we like to…
EatMoreFruit announces launch of European PR Network
EatMoreFruit, a UK top 10 independent healthcare communication agency, today announced the launch of its European Network to support new and existing clients across the diagnostics, med tech, life sciences,…
What if you could shape your next campaign messaging with the media before launch?
Sometimes you just can’t see the wood from the trees. Teams gets so focussed on the technology or treatment you’re selling that the inevitable outcome is a feature-peddling monologue where…
- 1
- 2